Arvinas' Series C Round

Arvinas raised a round of funding on April 04, 2018.

Arvinas is a pharmaceutical company focused on developing new small molecules aimed at degrading disease-causing cellular proteins. The company is translating these protein degradation approaches into…

Articles about Arvinas' Series C Round: